Our Cardiothoracic Imaging Section had a strong presence at the Annual North American Society for Cardiovascular Imaging Meeting, NASCI 2025. Dr. Surabhi Agarwal was one of five Young Investigator finalists who presented her research paper, which she conducted under Dr. Litmanovich's mentorship,...
Entitled: Mapping mechanosensory circuits from the bladder to Barrington's nucleus Open positions for interested and motivated candidates Detecting sensations from within our bodies, a process called interoception, is critical to drive many physiological processes. Stretch signals from the bladder...
How to join Studying Respiratory Illnesses We want to learn how respiratory illnesses spread, how they impact people's lives, and what we can do to stop people from getting sick. Study activities include surveys, nasal swabs and blood draws for some participants. Enrolling in the Greater Boston Area...
Learn more here: How to join the Boston DISCOVERY study What is DISCOVERY? The DISCOVERY of Risk Factors for Type 2 Diabetes in Youth Study is a national effort to learn about the causes of type 2 diabetes in children. It is a multi-center study at 15 locations across the United States. The study is...
The SAFE-CLTI (Critical Limb-Threatening Ischemia) initiative, a collaboration between the Smith Center and FDA, investigates: Trends in site-of-service for CLTI care Disparities in access and outcomes Comparative effectiveness of endovascular strategies Patient-centered outcomes like mobility and...
The Richard A. and Susan F. Smith Center for Outcomes Research was officially launched on November 1, 2015. In tandem with the recruitment of Dr. Robert Gerszten, Dr. Peter Zimetbaum hired Dr. Robert Yeh (Director) to start a new center focused on outcomes research supported by a generous gift from...
The Interventional Cardiology and Vascular Research Section was well-represented at this year's AHA conference, which took place in New Orleans. Mentees Dr. Joe Kim, Dr. Nathan Watson, and Dr. Herzig gave fantastic presentations on the topics of pulmonary embolism therapies, antiphospholipid...
We welcome Ari to join us as a visiting PhD student. Ari will spend 6 months of her doctoral studies with us to develop AI/ML models for our drug discovery projects. We hope that Ari will enjoy her time in Boston!